Collegium Pharmaceutical, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
36.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
0.01
|
0.14
|
107.69%
|
|
2022-06-30
|
1.42
|
-0.15
|
-1.57
|
-110.56%
|
|
2022-03-31
|
0.90
|
-0.39
|
-1.29
|
-143.33%
|
|
2021-12-31
|
1.04
|
-0.51
|
-1.55
|
-149.04%
|
|
2021-09-30
|
0.95
|
0.22
|
-0.73
|
-76.84%
|
|
2021-06-30
|
0.47
|
0.83
|
0.36
|
76.60%
|
|
2021-03-31
|
0.42
|
0.96
|
0.54
|
128.57%
|
|
2020-12-31
|
0.39
|
0.20
|
-0.19
|
-48.72%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.53
|
|
2021-12-31
|
1.50
|
|
2020-12-31
|
0.76
|
|
2019-12-31
|
-0.68
|
|
2018-12-31
|
-1.20
|
|
2017-12-31
|
-2.50
|
|
2016-12-31
|
-3.88
|
|
2015-12-31
|
-2.02
|